GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

Sanjana discusses the large question his lab is trying to answer: "How can we efficiently identify which regions or genome drive disease?" ...

In part one, Shapiro discusses her scientific journey, her trailblazing work in ancient DNA, and updates on Colossal projects.

He described how we move forward to increase the use of CRISPR in the clinic and how to streamline the process by which this ...

New tools and delivery vehicles for CRISPR are only truly beneficial if we can simultaneously improve the affordability and access.

Large-scale study defines genetic architecture of stuttering; findings point to 48 genes associated and highlight neurological risk pathways.